Search
for
Sort by
Research 14
- BindingDB Entry 50021519: Discovery of (2S)-N-(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia Treatment.
- Discovery of (2<i>S</i>)-<i>N</i>-(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia Treatment
- High spatial resolution study of human skin using synchrotron infrared microscopy: application to the penetration of external agents
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- Role of skin enzymes in metabolism of topical drugs
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Selective Sensing of Darolutamide and Thalidomide in Pharmaceutical Preparations and in Spiked Biofluids
- Progress in Topical and Transdermal Drug Delivery Research—Focus on Nanoformulations
- Solubility of Foreign Molecules in Stratum Corneum Brick and Mortar Structure
- Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents
- Recent Insights into the Potential and Challenges of Sericin as a Drug Delivery Platform for Multiple Biomedical Applications
- Self-assembling peptide inspired by insulin and type 1 insulin-like growth factor for the treatment of androgenetic alopecia
- Immune and Non-immune Interactions in the Pathogenesis of Androgenetic Alopecia
- Synthetic Approaches for Pharmacologically Active Decorated Six-Membered Diazines